Treatments in Schizophrenia

226 Pages·2014·28.7 MB·English

Pharmacological and Psychosocial
Treatments in Schizophrenia
Willey Campbell
Pharmacological and Psychosocial Treatments
in Schizophrenia

Pharmacological and Psychosocial
Treatments in Schizophrenia
Edited by Willey Campbell
Orange Apple,
5 Penn Plaza,
19th Floor,
New York, NY 10001, USA
© Orange Apple, 2017
This book contains information obtained from authentic and highly regarded sources. Copyright for all individual
chapters remain with the respective authors as indicated. All chapters are published with permission under the
Creative Commons Attribution License or equivalent. A wide variety of references are listed. Permission and sources
are indicated; for detailed attributions, please refer to the permissions page and list of contributors. Reasonable
efforts have been made to publish reliable data and information, but the authors, editors and publisher cannot
assume any responsibility for the validity of all materials or the consequences of their use.
ISBN: 978-1-9789-2763-6
The publisher’s policy is to use permanent paper from mills that operate a sustainable forestry policy. Furthermore,
the publisher ensures that the text paper and cover boards used have met acceptable environmental accreditation
standards.
Copyright of this ebook is with Orange Apple, rights acquired from the original print publisher, Hayle Medical.
Trademark Notice: Registered trademark of products or corporate names are used only for explanation and
identification without intent to infringe.
Cataloging-in-Publication Data
Pharmacological and psychosocial treatments in schizophrenia / edited by Willey Campbell.
p.cm.
Includes bibliographical references and index.
ISBN 978-1-9789-2763-6
1.Schizophrenia. 2. Schizophrenia--Treatment. 3. Schizophrenia--Chemotherapy.
4.Psychotherapy. I. Campbell, Willey.
RC514 .P43 2017
616.898--dc23
Table of Contents
Preface ..........................................................................................................................................................IX
Chapter 1 Age-Related Increase in the Number of Oligodendrocytes is Dysregulated in
Schizophrenia and Mood Disorders ........................................................................................................1
Victor Vostrikov and Natalya Uranova
Chapter 2 Clinical Practice Associated with a Switch from and to Ziprasidone during
Routine Inpatient Treatment of Patients with Schizophrenia..........................................................11
Matthias J. Müller
Chapter 3 Cannabinoids for the Treatment of Schizophrenia? A Balanced Neurochemical
Framework for both Adverse and Therapeutic Effects of Cannabis use ........................................18
Carissa M. Coulston, Michael Perdices, Antony F. Henderson, and Gin S.Malhi
Chapter 4 Health-Related Quality of Life and Overall Life Satisfaction in People with
Serious Mental Illness ..............................................................................................................................27
Amy L. Barnes,Meghan E.Murphy, Christopher A. Fowler, and Melisa V. Rempfer
Chapter 5 Role of Long-Acting Injectable Second-Generation Antipsychotics in
the Treatment of First-Episode Schizophrenia.....................................................................................33
Radovan Přikryl, Hana Přikrylovà Kučerovà, Michaela Vrzalovà, and Eva Češkovà
Chapter 6 Dissecting the Syndrome of Schizophrenia: Progress toward Clinically
useful Biomarkers .....................................................................................................................................40
Brian Dean
Chapter 7 Parietal Lobes in Schizophrenia: Do They Matter?.............................................................................50
Murat Yildiz, Stefan J. Borgwardt, and Gregor E. Berger
Chapter 8 Long-Acting Injectable Antipsychotics for First-Episode Schizophrenia: The Pros
and Cons ......................................................................................................................................................65
Borah Kim, Sang-Hyuk Lee, Yen Kuang Yang, Jong-Il Park, and Young-Chul Chung,
Chapter 9 Hospitalisation Utilisation and Costs in Schizophrenia Patients in Finland
before and after Initiation of Risperidone Long-Acting Injection ..................................................73
Christian Asseburg, Michael Willis, Mickael Löthgren, Niko Seppälä, Mika Hakala,
and Ulf Persson
Chapter 10 Examining the Factors Associated with Paid Employment of Clients Enrolled in
First Episode of Psychosis Programs......................................................................................................82
Carolyn S. Dewa, Lucy Trojanowski, Chiachen Cheng and Desmond Loong
Chapter 11 Do People with Schizophrenia Lack Emotional Intelligence? .........................................................89
Sara Dawson, Lisa Kettler, Cassandra Burton, and Cherrie Galletly
__________________________WORLD TECHNOLOGIES__________________________
VI Contents
Chapter 12 Schizophrenia and Suicide Attempts: Findings from a Representative
Community-Based Canadian Sample....................................................................................................97
Esme Fuller-Thomson and Bailey Hollister
Chapter 13 Schizophrenia as a Disorder of Social Communication...................................................................108
Cynthia Gayle Wible
Chapter 14 The Psychotomimetic Nature of Dreams.............................................................................................120
Oliver Mason and Dominic Wakerley
Chapter 15 Evaluation of Factors Affecting Continuous Performance Test Identical
Pairs Version Score of Schizophrenic Patients in a Japanese Clinical Sample ...........................124
Takayoshi Koide, Branko Aleksic, Tsutomu Kikuchi, Masahiro Banno,
Kunihiro Kohmura, Yasunori Adachi, Naoko Kawano, Tetsuya Iidaka and
Norio Ozaki
Chapter 16 Faulty Suppression of Irrelevant Material in Patients with Thought Disorder
Linked to Attenuated Frontotemporal Activation.............................................................................129
S. M. Arcuri, M. R. Broome, V. Giampietro, E. Amaro Jr., T. T. J. Kircher,
S. C. R. Williams, C. M. Andrew, M. Brammer, R. G. Morris and P. K. McGuire
Chapter 17 Treatment Adherence with Early Prescription of Long-Acting Injectable
Antipsychotics in Recent-Onset Schizophrenia ................................................................................141
Annie Viala, Françoise Cornic and Marie-Noëlle Vacheron
Chapter 18 Weight Gain, Schizophrenia and Antipsychotics: New findings from Animal
Model and Pharmacogenomic Studies ................................................................................................146
Fabio Panariello, Vincenzo De Luca and Andrea de Bartolomeis
Chapter 19 Sex Differences in Facial, Prosodic, and Social Context Emotional Recognition in
Early-Onset Schizophrenia ....................................................................................................................162
Julieta Ramos-Loyo, Leonor Mora-Reynoso, Luis Miguel Sánchez-Loyo and
Virginia Medina-Hernández
Chapter 20 Jumping to Conclusions is Associated with Paranoia but not General
Suspiciousness: A Comparison of Two Versions of the Probabilistic
Reasoning Paradigm................................................................................................................................174
Steffen Moritz, Niels Van Quaquebeke and Tania M. Lincoln
Chapter 21 Neurocognitive and Social Cognitive Approaches for Improving Functional
Outcome in Early Psychosis: Theoretical Considerations and Current State
of Evidence................................................................................................................................................183
Cali F. Bartholomeusz and Kelly Allott
Chapter 22 Intervention to Prevent Child Custody Loss in Mothers with Schizophrenia ............................198
Mary V. Seeman
__________________________WORLD TECHNOLOGIES__________________________
Contents VII
Chapter 23 Second Generation Antipsychotics Improve Sexual Dysfunction in
Schizophrenia............................................................ ...............................................................................204
Ahmed Mahmoud, Karen P. Hayhurst, Richard J. Drake, and Shôn W. Lewis
Permissions
List of Contributors
Index
__________________________WORLD TECHNOLOGIES__________________________
__________________________WORLD TECHNOLOGIES__________________________
Preface
Schizophrenia is a mental disorder that causes long-term damage to a person’s mind. Hallucinations,
delusions, altered states of perception and confusion are common symptoms of this disease. This book on
schizophrenia deals with the medication and psychological treatment that are available in the treatment
of schizophrenia. Cognitive behavioral therapy, antipsychotic medication, etc. are effective treatments
against this disease. This book, with its detailed analyses and data, will prove immensely beneficial to
professionals and students involved in this area at various levels. A number of latest researches have
been included to keep the readers up-to-date with the global concepts in this area of study. It is a vital
tool for all researching and studying this field.
Significant researches are present in this book. Intensive efforts have been employed by authors to make
this book an outstanding discourse. This book contains the enlightening chapters which have been
written on the basis of significant researches done by the experts.
Finally, I would also like to thank all the members involved in this book for being a team and meeting
all the deadlines for the submission of their respective works. I would also like to thank my friends
and family for being supportive in my efforts.
Editor
__________________________WORLD TECHNOLOGIES__________________________